Predictive value of <scp>ALT</scp> levels for non‐alcoholic steatohepatitis (<scp>NASH</scp>) and advanced fibrosis in non‐alcoholic fatty liver disease (<scp>NAFLD</scp>)

Verma, Siddharth; M. Jensen, Donald; Hart, John; R. Mohanty, Smruti

doi:10.1111/liv.12226

Public

Predictive value of ALT levels for non‐alcoholic steatohepatitis (NASH) and advanced fibrosis in non‐alcoholic fatty liver disease (NAFLD)

Published in Liver International • May 21, 2013

Authors:

Siddharth Verma

Donald M. Jensen

John Hart

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) patients with elevated serum alanine aminotransferase (ALT) generally undergo a liver biopsy to evaluate for possible non-alcoholic steatohepatitis (NASH) or advanced fibrosis. However, patients with normal ALT could also have advanced stages of ...

Subject

Steatohepatitis

Fatty liver

Fibrosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!